Motohiro Kamei, M.D.’s career in ophthalmology began with training under Professor Reizo Manabe (Cornea specialist) at Osaka University for 2 years, followed by a vitreoretinal fellowship with Yasuo Tano, M.D. at Osaka National Hospital.
During his fellowship (in 1992), he developed a novel surgical technique with tPA and liquid perfluorocarbon for evacuating submacular hemorrhage associated with age-related macular degeneration.
In 1995, he received an academic position in the Department of Ophthalmology at Osaka University with Professor Tano.
From 1996 to 1999, he worked with Hilel Lewis, M.D. and Joe G Hollyfield, Ph.D. at Cleveland Clinic Foundation as an international fellowship. His research focused on AMD; revealed accumulation of TIMP-3 with age and more in AMD lesion, intravitreal tPA penetration through the retina with subretinal hemorrhage and a novel surgical modification of limited macular translocation with out-pouching the sclera using titanium clips. He also studied on biodegradable drug delivery system for preventing proliferative vitreoretinopathy (PVR) after establishing a pig PVR model, for which he received 1st place for1999 F. Merlin Bumpus Ph.D. Junior Investigator Award.
After returning to Japan, he transiently moved to Kyoto Prefectural University of Medicine and assumed a chief of the vitreoretinal service for one and half years (2000-2002). After that, he became an associated professor followed by a professor at Osaka University Hospital in 2011.
He assumed a chairman of Ophthalmology at Aichi Medical University in 2015. He performed more than 4000 vitreoretinal surgeries. His research projects have three topics: optics of heads-up surgery, surgical and pharmacological treatments for retinal vein occlusion, and retinal prosthesis.